S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
NASDAQ:ZYXI

Zynex - ZYXI Stock Forecast, Price & News

$13.64
-0.57 (-4.01%)
(As of 02/3/2023 09:05 PM ET)
Add
Compare
Today's Range
$13.27
$14.69
50-Day Range
$13.32
$16.80
52-Week Range
$4.97
$17.25
Volume
737,200 shs
Average Volume
280,400 shs
Market Capitalization
$510.82 million
P/E Ratio
29.02
Dividend Yield
N/A
Price Target
$17.17

Zynex MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
25.9% Upside
$17.17 Price Target
Short Interest
Bearish
16.89% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.03mentions of Zynex in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$15,420 Sold Last Quarter
Proj. Earnings Growth
20.93%
From $0.43 to $0.52 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.33 out of 5 stars

Medical Sector

228th out of 1,025 stocks

Electromedical Equipment Industry

4th out of 24 stocks

ZYXI stock logo

About Zynex (NASDAQ:ZYXI) Stock

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. The company was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Receive ZYXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter.

ZYXI Stock News Headlines

Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Zynex Reports Preliminary Fourth Quarter 2022 Results
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Zynex Announces 2022 Third Quarter Earnings
Earnings Outlook For Zynex
Zynex Reports Preliminary Third Quarter 2022 Results
See More Headlines
Receive ZYXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter.

ZYXI Company Calendar

Last Earnings
11/02/2021
Today
2/06/2023
Next Earnings (Estimated)
2/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZYXI
Fax
N/A
Employees
774
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$17.17
High Stock Price Forecast
$21.00
Low Stock Price Forecast
$12.50
Forecasted Upside/Downside
+25.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$17.10 million
Pretax Margin
16.06%

Debt

Sales & Book Value

Annual Sales
$130.30 million
Cash Flow
$0.51 per share
Book Value
$1.93 per share

Miscellaneous

Free Float
21,565,000
Market Cap
$510.82 million
Optionable
Optionable
Beta
0.66

Key Executives

  • Thomas SandgaardThomas Sandgaard
    Chairman, President & Chief Executive Officer
  • Anna Lucsok
    Chief Operating Officer
  • Daniel J. MoorheadDaniel J. Moorhead
    Chief Financial Officer
  • Chelle van Burkleo
    Vice President-Sales
  • Dave Anttila
    Director-Human Resources













ZYXI Stock - Frequently Asked Questions

Should I buy or sell Zynex stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ZYXI shares.
View ZYXI analyst ratings
or view top-rated stocks.

What is Zynex's stock price forecast for 2023?

3 brokers have issued 12 month price objectives for Zynex's shares. Their ZYXI share price forecasts range from $12.50 to $21.00. On average, they expect the company's share price to reach $17.17 in the next year. This suggests a possible upside of 25.9% from the stock's current price.
View analysts price targets for ZYXI
or view top-rated stocks among Wall Street analysts.

How have ZYXI shares performed in 2023?

Zynex's stock was trading at $13.91 at the beginning of 2023. Since then, ZYXI stock has decreased by 1.9% and is now trading at $13.64.
View the best growth stocks for 2023 here
.

When is Zynex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our ZYXI earnings forecast
.

How were Zynex's earnings last quarter?

Zynex, Inc. (NASDAQ:ZYXI) issued its quarterly earnings results on Tuesday, November, 2nd. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.05. The business earned $34.79 million during the quarter, compared to analyst estimates of $35.42 million. Zynex had a trailing twelve-month return on equity of 26.05% and a net margin of 12.35%.

What guidance has Zynex issued on next quarter's earnings?

Zynex issued an update on its fourth quarter 2022 earnings guidance on Tuesday, January, 17th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $48.00 million-$51.00 million, compared to the consensus revenue estimate of $49.71 million.

What is Thomas Sandgaard's approval rating as Zynex's CEO?

81 employees have rated Zynex Chief Executive Officer Thomas Sandgaard on Glassdoor.com. Thomas Sandgaard has an approval rating of 87% among the company's employees.

What is Zynex's stock symbol?

Zynex trades on the NASDAQ under the ticker symbol "ZYXI."

Who are Zynex's major shareholders?

Zynex's stock is owned by a number of retail and institutional investors. Top institutional investors include Rice Hall James & Associates LLC (0.49%), Bridge City Capital LLC (0.35%), Janney Montgomery Scott LLC (0.17%), Legato Capital Management LLC (0.12%), Yousif Capital Management LLC (0.06%) and Platte River Wealth Advisors LLC (0.05%). Insiders that own company stock include Anna Lucsok, Daniel J Moorhead and Thomas Sandgaard.
View institutional ownership trends
.

How do I buy shares of Zynex?

Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zynex's stock price today?

One share of ZYXI stock can currently be purchased for approximately $13.64.

How much money does Zynex make?

Zynex (NASDAQ:ZYXI) has a market capitalization of $510.82 million and generates $130.30 million in revenue each year. The company earns $17.10 million in net income (profit) each year or $0.47 on an earnings per share basis.

How many employees does Zynex have?

The company employs 774 workers across the globe.

How can I contact Zynex?

Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The official website for the company is www.zynex.com. The company can be reached via phone at (303) 703-4906 or via email at info@zynex.com.

This page (NASDAQ:ZYXI) was last updated on 2/6/2023 by MarketBeat.com Staff